Many people take low-dose aspirin daily in hopes of preventing heart problems. Now, The researchers found that women who took regular low-dose aspirin – usually 81 mg – were 23% less likely to develop ovarian cancer than women not taking this type of aspirin. The discovery, published in JAMA Oncology, examined the medical data of 205,498 women, including the use of low-dose aspirin, aspirin at standard dose (325 mg), d & rsquo; acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) not containing aspirin. like ibuprofen and naproxen. In more than two decades, 1,054 women have developed ovarian cancer. Although people taking low-dose aspirin have a lower risk of cancer, it has been found that there is no beneficial relationship between developing ovarian cancer and taking aspirin or standard dose acetaminophen. In fact, the researchers wrote that "their findings suggest that intensive use of [NSAIDs] may be associated with an increased risk of ovarian cancer.
Although this is not common, ovarian cancer is the most deadly type of gynecological cancer. Women usually have no symptoms at an early stage of the disease. Therefore, it is often only detected when the cancer is advanced and it has spread, which makes it much more difficult to treat. Regularly taking low dose aspirin is not suitable for everyone. This can increase the risk of bleeding and lead to stomach ulcers. Talk with your doctor before starting a daily aspirin regimen.
– Linda Searing
